UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

The syntax of comparison constructions in diachronic and dialectal perspective

Glossa (London), 2019-06, Vol.4 (1), p.1-51

Jäger, Agnes

2019

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?

Cancer treatment reviews, 2015-02, Vol.41 (2), p.144-150

2015

Link zum Volltext

Verfügbarkeit prüfen

Mehr als (wie) die Summe seiner Teile: Vergleichspartikeln in den Dialekten Hessens mit besonderer Berücksichtigung von als wie

Zeitschrift für Dialektologie und Linguistik, 2013, Vol.80 (3), p.261-296

Jäger, Agnes

2013

Link zum Volltext

Verfügbarkeit prüfen

ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients

Cancer treatment reviews, 2017-01, Vol.52, p.33-40

2017

Link zum Volltext

Verfügbarkeit prüfen

Individualization of tamoxifen therapy: Much more than just CYP2D6 genotyping

Cancer treatment reviews, 2015-03, Vol.41 (3), p.289-299

2015

Link zum Volltext

Verfügbarkeit prüfen

Negation in Old High German

Zeitschrift für Sprachwissenschaft, 2005-11, Vol.24 (2), p.227-262

Jäger, Agnes

2005

Link zum Volltext

Verfügbarkeit prüfen

Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation

Cancers, 2021-02, Vol.13 (5), p.1004

2021

Link zum Volltext

Verfügbarkeit prüfen

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review

International journal of molecular sciences, 2023-02, Vol.24 (3), p.2969

2023

Link zum Volltext

Verfügbarkeit prüfen

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines

PloS one, 2019-05, Vol.14 (5), p.e0216400-e0216400

2019

Link zum Volltext

Verfügbarkeit prüfen

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases

Scientific reports, 2022-07, Vol.12 (1), p.12974-12974, Article 12974

2022

Link zum Volltext

Verfügbarkeit prüfen

Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab

Breast (Edinburgh), 2020-08, Vol.52, p.71-77

2020

Link zum Volltext

Verfügbarkeit prüfen

Adverse health effects after breast cancer up to 14 years after diagnosis

Breast (Edinburgh), 2022-02, Vol.61, p.22-28

2022

Link zum Volltext

Verfügbarkeit prüfen

Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands

Biomedicine & pharmacotherapy, 2023-02, Vol.158, p.114158-114158, Article 114158

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice

Breast (Edinburgh), 2020-08, Vol.52, p.33-44

2020

Link zum Volltext

Verfügbarkeit prüfen

Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling

Cancers, 2023-09, Vol.15 (17), p.4416

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor

Neoplasia (New York, N.Y.), 2016-11, Vol.18 (11), p.647-653

2016

Link zum Volltext

Verfügbarkeit prüfen

Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale

Biomedicine & pharmacotherapy, 2023-04, Vol.160, p.114369-114369, Article 114369

2023

Link zum Volltext

Verfügbarkeit prüfen

Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels

Scientific reports, 2023-06, Vol.13 (1), p.10424-10424, Article 10424

2023

Link zum Volltext

Verfügbarkeit prüfen

Der Komparativzyklus und die Position der Vergleichspartikeln

Linguistische Berichte, 2010, Vol.224 (224), p.467-493

Jäger, Agnes

2010

Link zum Volltext

Verfügbarkeit prüfen

The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer

Biomedicine & pharmacotherapy, 2024-01, Vol.170, p.115969-115969, Article 115969

2024

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients

Molecular oncology, 2018-01, Vol.12 (1), p.48-57

2018

Link zum Volltext

Verfügbarkeit prüfen

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?

Cancers, 2021-05, Vol.13 (11), p.2506

2021

Link zum Volltext

Verfügbarkeit prüfen

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane

Molecular oncology, 2020-03, Vol.14 (3), p.490-503

2020

Link zum Volltext

Verfügbarkeit prüfen

The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer

Breast (Edinburgh), 2020-08, Vol.52, p.102-109

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Aktive Filter

KollektionIngenta.com

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(93)
Reviews
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The syntax of comparison constructions in diachronic and dialectal perspective

Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?

Mehr als (wie) die Summe seiner Teile: Vergleichspartikeln in den Dialekten Hessens mit besonderer Berücksichtigung von als wie

ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients

Individualization of tamoxifen therapy: Much more than just CYP2D6 genotyping

Negation in Old High German

Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review

MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases

Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab

Adverse health effects after breast cancer up to 14 years after diagnosis

Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands

Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice

Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor

Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale

Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels

Der Komparativzyklus und die Position der Vergleichspartikeln

The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane

The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study

Aktive Filter

Suchergebnisse filtern